New viscodissection instrument successful for treating retinal detachments

Article

A newly developed method for microincisional vitrectomy is effective for complex diabetic tractional retinal detachment, according to a study published in the Archives of Ophthalmology.

A newly developed method for microincisional vitrectomy is effective for complex diabetic tractional retinal detachment, according to a study published in the Archives of Ophthalmology.

Dr Jorge A. Fortun et al., Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, conducted a single-surgeon, noncomparative, consecutive case series on 30 eyes with severe diabetic tractional retinal detachment. All patients underwent viscodissection-assisted 25-gauge vitrectomy with the new instrument.

The mean visual acuity was 20/400 preoperatively. Mean postoperative visual acuity was measured at 20/70. In 17 eyes visual acuity increased by 2 or more lines and remained the same in 11 eyes.

Overall, the newly developed viscodisssection instrument successfully aids microincisional vitrectomy for complex diabetic tractional retinal detachment.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.